<p>At the conference, we presented about our project, MusCure. We shared with everyone the basic concept, design approach, and advantages of MusCure over traditional therapies. At that time, our project was facing a tricky problem: how to successfully colonize our engineered bacteria in the gut. In communication with other teams, we discussed the feasibility and efficiency of using IBD-specific markers as molecular switches to trigger the expression of the ASL3 adhesion protein downstream. Thanks to the communication among our peers, our team ultimately decided to use the IBD-specific marker system as our colonization system.</p>
<p>At the conference, we also distributed the pamphlet we designed to many teams. Our pamphlet includes an overview of IBD, symptoms and causes of IBD, diagnosis and treatment of IBD, an introduction to synthetic biology, and our project MusCure. The pamphlet aims to raise public awareness of IBD and understanding of synthetic biology in a simple way. Our pamphlet is available in four languages: Chinese, English, French, and Arabic. Besides, to cater to the needs of special groups, we have also designed a large print version and an audiobook version.</p>
<p>Peering into the horizon, our optimism for CCiC knows no bounds. As we march forward, we're eager to witness the innovative ideas and projects that will spring forth, driven by the youthful enthusiasm and creativity of conference attendees. Furthermore, we're excited about fostering global collaboration and knowledge exchange, bridging borders to contribute to the worldwide advancement of synthetic biology in healthcare and other domains.</p>
